[go: up one dir, main page]

MX2017002469A - Composiciones de matrices extracelulares. - Google Patents

Composiciones de matrices extracelulares.

Info

Publication number
MX2017002469A
MX2017002469A MX2017002469A MX2017002469A MX2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A
Authority
MX
Mexico
Prior art keywords
extracellular matrix
matrix compositions
compositions
cme
placental
Prior art date
Application number
MX2017002469A
Other languages
English (en)
Other versions
MX387756B (es
Inventor
Herzberg Uri
Ye Qian
Kaplunovsky Aleksandr
B Bhatia Mohit
ZAKA Raihana
Original Assignee
Hli Cellular Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hli Cellular Therapeutics Llc filed Critical Hli Cellular Therapeutics Llc
Publication of MX2017002469A publication Critical patent/MX2017002469A/es
Publication of MX387756B publication Critical patent/MX387756B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proporcionan aquí composiciones de matriz extracelular placentaria (CME) y métodos para fabricarlas. También se proporcionan usos de las composiciones placentarias CME proporcionadas en la presente memoria.
MX2017002469A 2014-08-25 2015-08-25 Composiciones de matríces extracelulares. MX387756B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462041468P 2014-08-25 2014-08-25
PCT/US2015/046690 WO2016033041A1 (en) 2014-08-25 2015-08-25 Extracellular matrix compositions

Publications (2)

Publication Number Publication Date
MX2017002469A true MX2017002469A (es) 2017-05-19
MX387756B MX387756B (es) 2025-03-18

Family

ID=55400430

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002469A MX387756B (es) 2014-08-25 2015-08-25 Composiciones de matríces extracelulares.

Country Status (16)

Country Link
US (1) US20170056479A1 (es)
EP (1) EP3185888B1 (es)
JP (4) JP2017525732A (es)
KR (2) KR20230129618A (es)
CN (1) CN106794227B (es)
AU (2) AU2015306811A1 (es)
BR (1) BR112017003905A2 (es)
CA (1) CA2958211C (es)
EA (1) EA201790461A1 (es)
IL (1) IL250753A0 (es)
MX (1) MX387756B (es)
MY (1) MY193650A (es)
NZ (1) NZ729021A (es)
SG (2) SG11201701114UA (es)
WO (1) WO2016033041A1 (es)
ZA (1) ZA201701059B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224767B2 (en) 2013-11-26 2022-01-18 Sanuwave Health, Inc. Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing
JP6712160B2 (ja) * 2016-03-29 2020-06-17 株式会社Adeka エンドトキシン測定のための前処理方法及びその測定方法
EP3474869B1 (en) 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
CA3032390A1 (en) * 2016-07-29 2018-02-01 Alliqua Biomedical, Inc. Systems and methods for delivering cellular and biological materials using ultrasound for wound treatment and healing
CN107349463A (zh) * 2017-06-16 2017-11-17 卓阮医疗科技（苏州）有限公司 一种生物源性止血微粒及其制备方法
US11026980B1 (en) * 2018-02-26 2021-06-08 Triad Life Sciences, Inc. Flowable birth tissue composition and related methods
CN109125799A (zh) * 2018-09-05 2019-01-04 张强 GelMA水凝胶人脱细胞羊膜三维双层辅料的制备方法
US20220195382A1 (en) * 2019-04-04 2022-06-23 THT Biomaterials GmbH A novel human-material-based platfom technology for tissue engineering
CN110841115A (zh) * 2019-11-13 2020-02-28 中国科学院遗传与发育生物学研究所 一种胶原凝胶支架及其在提高自体脂肪细胞移植存活率中的应用
CA3179245A1 (en) * 2020-05-26 2021-12-02 Jon G. Hargis Modified porcine scaffolds and methods of preparation
JP7189468B2 (ja) 2021-01-08 2022-12-14 ダイキン工業株式会社 不具合箇所推定システム、不具合箇所推定方法、及びプログラム
WO2025024825A1 (en) * 2023-07-26 2025-01-30 Celularity Inc. Decellularized placental extracellular matrix and uses thereof
CN118986769A (zh) * 2024-08-14 2024-11-22 欧诗漫生物股份有限公司 用于抑制光老化的ecm组合物及其在护肤品中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
CN1478547A (zh) * 2002-08-28 2004-03-03 赵晓红 胶原蛋白保健胶囊
WO2006071802A2 (en) * 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
WO2006099372A2 (en) * 2005-03-11 2006-09-21 Wake Forest University Health Sciences Tissue engineered blood vessels
AT502395B1 (de) * 2005-07-27 2007-03-15 Iep Gmbh Oxidoreduktasen zur stereoselektiven reduktion von ketoverbindungen
CN1739797A (zh) * 2005-09-06 2006-03-01 易康富生物科技(南通)有限公司 一种补充胶原蛋白的复合配方
EP1954802B1 (en) * 2005-10-31 2017-05-31 Bio Solution Co., Ltd. Artificial cartilage containing chondrocytes obtained from costal cartilage and preparation process thereof
AU2007318210B2 (en) * 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US20090023885A1 (en) * 2007-07-16 2009-01-22 Texas State University - San Marcos Treatment method for imparting high impact resistance in certain cbdo copolymers
EP2182971B1 (en) * 2007-07-27 2013-12-18 Humacyte, Inc. Compositions comprising human collagen and human elastin and uses thereof
WO2010053918A1 (en) * 2008-11-05 2010-05-14 Hancock Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
US20110020271A1 (en) * 2009-05-20 2011-01-27 Humacyte, Inc. Elastin for soft tissue augmentation
US8652500B2 (en) * 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
ES2768968T3 (es) * 2009-08-25 2020-06-24 Tissue Tech Inc Productos de la membrana amniótica del cordón umbilical
US9908691B2 (en) * 2010-06-30 2018-03-06 Gpcp Ip Holdings Llc Dispenser and sheet product dispensing plate therefor
US8722854B2 (en) * 2010-12-23 2014-05-13 Medskin Solutions Dr. Suwelack Ag Degradation-stabilised, biocompatible collagen matrices
US20120189586A1 (en) * 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
MX2015002710A (es) * 2012-09-04 2015-07-23 Anthrogenesis Corp Metodos de generacion de tejidos.
RU2015127077A (ru) * 2012-12-07 2017-01-12 Антродженезис Корпорейшн Лечение поражений полости рта при помощи внеклеточного матрикса плаценты
EP3027235A1 (en) * 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP3104865A4 (en) * 2014-02-11 2017-11-22 Anthrogenesis Corporation Micro-organoids, and methods of making and using the same

Also Published As

Publication number Publication date
SG10201901713RA (en) 2019-03-28
US20170056479A1 (en) 2017-03-02
MY193650A (en) 2022-10-21
JP2017525732A (ja) 2017-09-07
JP2022130466A (ja) 2022-09-06
CN106794227A (zh) 2017-05-31
EA201790461A1 (ru) 2017-07-31
KR20170040809A (ko) 2017-04-13
ZA201701059B (en) 2018-04-25
EP3185888B1 (en) 2023-06-07
CA2958211A1 (en) 2016-03-03
MX387756B (es) 2025-03-18
CA2958211C (en) 2023-09-26
CN106794227B (zh) 2022-03-01
KR20230129618A (ko) 2023-09-08
EP3185888A4 (en) 2018-06-20
NZ729021A (en) 2022-12-23
AU2015306811A1 (en) 2017-03-09
SG11201701114UA (en) 2017-03-30
AU2021202201A1 (en) 2021-05-06
WO2016033041A1 (en) 2016-03-03
EP3185888A1 (en) 2017-07-05
IL250753A0 (en) 2017-04-30
JP2020142114A (ja) 2020-09-10
JP2024161378A (ja) 2024-11-19
BR112017003905A2 (en) 2018-03-06

Similar Documents

Publication Publication Date Title
MX2017002469A (es) Composiciones de matrices extracelulares.
CL2016001871A1 (es) Anticuerpos humanos para pd-1
EP3420396A4 (en) PUPIL ENLARGEMENT
IL248519A0 (en) Bioceramic compositions and biomodulatory uses thereof
ECSP17023281A (es) Inhibidores de mk2 y sus usos
BR112016030368A2 (pt) composição oftálmica
EP3547968A4 (en) PROSTHESIS OBTAINED BY TISSUE ENGINEERING
CL2016003416A1 (es) Herbicidas de piperidinona
LT3426226T (lt) Oftalmologinė kompozicija
EP3331345A4 (en) Hedge trimmer
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
DK3452093T3 (da) Ophthalmiske sammensætninger
DE112015003841A5 (de) Di- und triphosphat-propharmaka
MX382864B (es) Formulaciones de anticuerpos cristalinos.
CO2017010621A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
PL3799932T3 (pl) Kompozycja środka wspomagającego golenie
EP3409134A4 (en) TROUSERS
ITUA20163470A1 (it) Formulazione antiappannante
DK3194574T3 (da) Fremgangsmåde til dyrkning af stamceller in vitro
EP3446682A4 (en) OPHTHALMIC COMPOSITION
ES1186859Y (es) Conjunto de extensiones para gafas
PE20180574A1 (es) Lisobactina para su uso en el tratamiento de la mastitis bovina
CL2018000123A1 (es) Criopreservación de embriones de ungulados
DK3490577T3 (da) Sammensætninger til hud, omfattende turmeroner